Winning a £50,000 Innovate UK grant feels like a result worth celebrating, and it is. But the moment the cash lands in the business bank account, a less exciting question arrives with it: how do you actually put this through the books? Many SME owners and even experienced bookkeepers default to recognising the full £50,000 as income straight away, because that is what the bank statement seems to suggest happened. The trouble is, that single decision can distort your profit for the year, confuse a lender or investor reading your accounts, trigger awkward questions from your accountant at year end, and in some cases create a mismatch with how HMRC expects R&D tax relief to be calculated. This article walks through, with real numbers, exactly how a government grant like this should be treated under IAS 20 and FRS 102 — and why getting the timing right matters just as much as getting the amount right.
What exactly is a government grant for accounting purposes?
A government grant is assistance from a government body, or a body acting on its behalf such as Innovate UK, given in exchange for the recipient meeting certain conditions. Crucially, it is not a loan (there is usually nothing to repay if conditions are met) and it is not equity (the government does not take a shareholding). Because of that, accounting standards treat grants as a form of income — but income that relates to a specific purpose, usually covering costs you are incurring over a period of time, such as a twelve-month research and development project. The core idea that both IAS 20 and FRS 102 share is simple: a grant should be recognised in profit or loss in the same periods as the costs it is meant to compensate, not dumped into income the moment the cash is received. Think of it like a season ticket refund tied to how many games you have actually attended — you would not book the whole refund as a one-off win on day one; you would spread it against each match as it happens.
IAS 20 and FRS 102 — same principle, slightly different toolkit
Both standards agree that grant income should be matched to the expenditure it is designed to cover. Where they differ is in presentation options and model choices. IAS 20 requires an income approach: for income-related grants, entities may present income separately or deduct it from the related expense; for asset-related grants, entities can either recognise deferred income released over time or deduct the grant from the asset’s carrying amount. FRS 102 (Section 24) offers UK companies an accounting policy choice between a performance model (recognising the grant in income once specific performance conditions are met) and an accrual model (matching grant income against related costs over time). Crucially, under FRS 102 and UK company law, offsetting is prohibited: capital grants cannot be deducted from the cost of an asset, and revenue grants cannot be netted against expenses.
| Aspect | IAS 20 | FRS 102 (Section 24) |
|---|---|---|
| Core principle | Match grant income to related costs over time | Match grant income to costs over time (accrual model) or recognise when conditions are met (performance model) |
| Models available | Income approach only (capital approach not permitted) | Choice of performance model or accrual model |
| Grant received before conditions met | Recognise as deferred income (liability), not as income | Recognise as deferred income (liability), not as income |
| Grant related to a capital asset | Deduct from asset cost or show as deferred income, released over asset life | Must show as deferred income (accrual model) or recognise once conditions met; netting against asset cost is prohibited |
| Typical SME choice for an R&D grant | Accrual approach, released as costs are incurred | Accrual model, released as costs are incurred |
Worked example: a £50,000 Innovate UK grant for an R&D project
Let’s take a realistic case. TechFab Ltd, a small manufacturing business, wins a £50,000 Innovate UK grant to help fund a twelve-month project developing a new sensor component. The total eligible project cost is budgeted at £120,000, meaning the grant covers roughly 42% of the project. Innovate UK pays the grant in two instalments: £30,000 upfront on signing the grant agreement, and £20,000 later once a milestone report is submitted and approved. By the company’s year end, ten months into the project, TechFab has incurred £70,000 of eligible costs — staff time, materials and testing fees. The question the finance team needs to answer is: how much of the £50,000 grant should be recognised as income in this year’s accounts?
| Total eligible project cost (budget) | £120,000 |
| Eligible costs incurred to year end | £70,000 |
| Proportion of project completed (£70,000 / £120,000) | 58.3% |
| Total grant awarded | £50,000 |
| Grant income to recognise this year (58.3% x £50,000) | £29,167 |
The logic here is straightforward once you see the numbers: because 58.3% of the project’s costs have actually been incurred, 58.3% of the grant is treated as having been earned, and that is the portion released to profit or loss. The remaining £833 of the £30,000 cash already received sits on the balance sheet as deferred income — a liability representing grant money received but not yet matched against spend. The remaining £20,833 of the total £50,000 award has not yet been earned or received, and should not be presented as profit.
| Item | Amount | Where it sits in the accounts |
|---|---|---|
| Cash received to date | £30,000 | Bank (asset) |
| Grant income recognised this year | £29,167 | Other operating income (profit or loss) |
| Deferred income balance carried forward | £833 | Liability on balance sheet |
| Second instalment (expected, not yet received) | £20,000 | Not yet recognised anywhere |
| Account | Dr | Cr |
|---|---|---|
| Bank | £30,000 | |
| Deferred income (grant received in advance) | £30,000 |
First instalment of the Innovate UK grant received on signing the grant agreement. Recognised as a liability, not income, because the related R&D costs have not yet been incurred.
| Account | Dr | Cr |
|---|---|---|
| Deferred income (grant received in advance) | £29,167 | |
| Grant income (other operating income) | £29,167 |
Release of grant income at year end, matched to the 58.3% of eligible project costs incurred to date (£70,000 of £120,000 budgeted project cost).
Where you present grant income matters too. Under FRS 102, UK company law prohibits setting off income against expenditure, so SMEs must present grant income gross — typically as ‘other operating income’ separate from turnover, rather than netting it against R&D expenses. Under IAS 20, netting against related expenses is an allowable option, but presenting it gross under other operating income remains standard good practice across both frameworks.
What happens if the conditions are not met?
Innovate UK grants, like most government grants, come with conditions attached — hitting project milestones, spending within the approved cost categories, and sometimes continuing to trade for a minimum period. If conditions are breached, some or all of the grant may become repayable. Because of this, any unreleased deferred income balance carries a degree of risk, and you should not treat it as guaranteed income until the relevant costs and conditions have genuinely been satisfied. If repayment becomes probable at any point, you need to recognise a provision and reverse any grant income already taken to profit or loss that related to the unmet condition. Build this risk into your cash flow forecast rather than assuming the full £50,000 is locked in.
Tax and compliance considerations for UK SMEs
Grant income is normally taxable as trading income for corporation tax purposes, and HMRC generally follows the accounting treatment for timing — so the £29,167 recognised in profit or loss this year is the figure that flows into your tax computation, not the £30,000 of cash received. The interaction with R&D tax relief also requires careful navigation. Under the UK subsidy control regime (and previously EU State aid rules), Innovate UK grants represent subsidised public funding. For accounting periods beginning on or after 1 April 2024, the UK merged R&D tax relief into a single merged scheme (an RDEC-style taxable credit), alongside the Enhanced R&D Intensive Scheme (ERIS) for loss-making R&D-intensive SMEs. Because expenditure funded by a grant cannot be double-counted, grant-funded costs cannot be claimed under ERIS or subsidised twice. In legacy periods prior to April 2024, receiving notified State aid disqualified an entire project from the SME R&D scheme, forcing all project costs into RDEC. The practical step is to maintain dedicated project accounts separating grant-funded spend from company-funded spend.
- Never book grant cash as income on arrival — set it up as deferred income (a liability) and release it to profit or loss only as you incur the costs it is meant to cover.
- Build a simple cost-tracking schedule that maps your grant agreement’s budget categories against actual spend each month, so you can recalculate the release percentage accurately at each reporting date.
- Check subsidy control and grant classifications before finalising R&D tax relief claims — public grants directly impact whether costs qualify under ERIS or the merged R&D scheme.
- Disclose the grant’s conditions, remaining performance obligations and any clawback risk in your accounts, and reflect that risk in your cash flow forecast rather than treating the full award as guaranteed.
Confused about grant accounting in your own accounts?
If your business has received an Innovate UK grant, a local authority grant, or any other form of government funding, getting the accounting treatment and R&D tax interaction right from the start saves time, protects your tax position, and keeps your accounts accurate for lenders and investors. We help SME owners and finance teams work through exactly these situations with practical, plain-English support.
